Speaker Profile
MD, PhD, Consultant Medical Oncologist, The Royal Marsden
Biography
Professor Popat is a Consultant Medical Oncologist at The Royal Marsden and Professor of Thoracic Oncology at the Institute of Cancer Research. Recognized globally for his expertise in lung cancer, mesothelioma, and thymic cancers, he qualified from Guys and St Thomas Hospitals in 1994 and later earned a PhD in Molecular Genetics in 2002. His research, which has won numerous awards, focuses on genetic profiling in cancer and the development of new drug treatments. Nationally, he chairs the British Thoracic Oncology Group (BTOG) Steering Committee and holds several roles within the NIHR. Internationally, he's active in the European Society of Medical Oncology (ESMO) and has contributed to European Clinical Practice Guidelines for various lung cancers. His collaborations have resulted in the global licensing of drugs and their inclusion in international treatment guidelines. Additionally, Professor Popat frequently serves as a Clinical Expert for NICE and advises multiple patient focused cancer charities.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Pioneer Honoree: Helmy Eltoukhy
Pioneer Honoree: AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy (PANEL)
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio
- Sylvia Katina Plevritis, Stanford - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, National Cancer Institute
- Sheila D. Walcoff, Goldbug Strategies LLC - Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - NCI Showcase
- Xiaohui Ni, Early Dx
- Daniel Kim, UCSC
